All In MedTech

Device Trial Radar · NCT07503171

Hypoxia and Hemodilution Testing in Healthy Adult Volunteers

Last checked: Nov 20, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

7

Planned (sponsor's estimate)

Start

Apr 2, 2026

Primary completion

Feb 1, 2027

Study completion Jan 31, 2028

Sponsor

Lead sponsor
Nihon KohdenNot on our public-company list
Sponsor type
Industry
First posted
Mar 31, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.

Conditions

  • Hypoxia
  • Hemodilution

Interventions

  • Noninvasive Physiological Monitoring DeviceDevice

    Octopal R Noninvasive Pulse Wave Measuring Device DMO-8000X with TL 811S Finger Probe

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Collection of Hemoglobin and Oxygen Saturation MeasurementsTime frame: From enrollment to the end of treatment up to 8 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vital Sign Research Group

    San Francisco, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.